This article covers why GLP-1 medications cause constipation, what the probiotic literature actually shows on transit time and constipation symptoms, and how to evaluate any probiotic claim aimed at GLP-1 users
Immunohistochemical staining for a lysosomal-associated protein and adipophilin may be used to differentiate phospholipidosis from conventional fatty change (Obert et al
While waiting for help, keep the person awake and sitting up if possible
Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial
Applications in Animal Aging Models Animal aging models (such as naturally aged mice, D-galactose-induced aging mice, SAMP8 accelerated senescence mice, etc.) are core carriers for simulating human aging and verifying the efficacy of anti-aging drugs
These effects occur because Lipo C accelerates fat metabolism while GLP-1 medications slow gastric emptying, creating conflicting metabolic signals